Infinity Pharmaceuticals, Inc. (INFI) Tops Q1 EPS by 6c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/26/2026
- Wall St set for higher open as Anthropic's IPO filing sharpens AI focus
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts INFI Hot Sheet
Join SI Premium – FREE
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) reported Q1 EPS of ($0.78), $0.06 better than the analyst estimate of ($0.84).
For earnings history and earnings-related data on Infinity Pharmaceuticals, Inc. (INFI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- New survey reveals Wall Street's consensus S&P 500 targets for end of 2026
- Customers Bancorp (CUBI) PT Raised to $107 at DA Davidson as Stock 'Very Undervalued'
- Ross Stores climbs as UBS upgrades shares to Buy on stronger sales outlook
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
